By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies said today that it has partnered with Integrated Diagnostics to develop multiplexed protein biomarker-based assays for detecting diseases in their early stages.

The firms plan to develop high-throughput automated workflows for sample preparation and liquid chromatography mass spectrometry analysis, with the goal of accelerating biomarker discoveries by enabling screening of several hundred biomarkers in a single assay.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.